This course is part of a series of OASIS-E courses for licensed professionals in home health care who may complete the OASIS-E. The purpose of this course is to present content that guides clinicians in how to code appropriately within Section N.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.50 contact hours for participating in this course.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
Kansas State Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.50 contact hours for participating in this course.
Michigan Board of Nursing (CEBroker Provider #50-290)
Mississippi Board of Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
Texas HHSC has determined that Relias' submitted training meets or exceeds the minimum standards for HCSSA administrator training in the following categories: Licensed Home Health, Licensed and Certified Home Health, Personal Assistance Services, Hospice. Texas HHSC also recognizes Relias provides continuing education for administrators and alternate administrators. This activity is approved for 1.50 contact hours.
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Wyoming Board of Nursing (CEBroker Provider #50-290)
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Section N: Medications
General Overview
N0415: High-Risk Drug Classes: Use and Indication
M2001 to M2005: Potential or Actual Clinically Significant Medication Issues
M2010: Patient/Caregiver High-Risk Drug Education
M2020 and M2030 Medication Management
Summary
Section 3: Conclusion
Course Summary
Course Contributors
Resources
Reference
Sherry is a nursing professional with over 21 years of experience. She holds an Associate Degree in Nursing from Randolph Community College, a Bachelor of Science in Nursing from the University of North Carolina at Greensboro, and a Master of Science in Nursing from Walden University. Her expertise encompasses oncology and hematology, home healthcare, hospice and palliative care, healthcare education, nursing consultative services, performance improvement, quality assurance, and regulatory compliance. Throughout her career, Sherry has demonstrated unwavering dedication to patient care and made significant contributions to healthcare education. She is committed to improving patient outcomes through education and quality assurance.Reviewer: Jennifer W. Burks, M.S.N., R.N.
Jennifer has over 30 years of clinical and teaching experience, and her areas of expertise are critical care and home health. She is certified as an OASIS Specialist- Clinical (COS-C) and is a Curriculum Designer in post-acute care for Relias. She earned her Bachelor of Science in Nursing from The University of Virginia in 1993 and her Master of Science in Nursing from The University of North Carolina, Greensboro in 1996. Her professional practice in education is guided by a philosophy borrowed from Florence Nightingale’s Notes on Nursing, “I do not pretend to teach her how, I ask her to teach herself, and for this purpose, I venture to give her some hints.”
Access to over 1,450 courses! Access to 1,450+ courses for one low price.